J17 Capital is a Canadian venture capital firm that specializes in growth equity investments, targeting middle to late-stage companies across North America. Their strategy focuses on partnering with growth-oriented businesses in diverse industries, with a particular emphasis on technology sectors such as consumer technologies, Web3, AI, and blockchain, to foster innovation and drive value creation.
Portfolio
1
Fund Size
—
Top Stage
Series B
Last 12 Mo
1
Stage Distribution
Portfolio
1 investment
| Company | Round | Amount | Date |
|---|---|---|---|
| Cambium Biomaterials | Series B | $100M | Jan 2026 |
Top Co-Investors
8VC1 shared
MVP Ventures1 shared
Lockheed Martin Ventures1 shared
GSBackers1 shared
Veteran Ventures Capital1 shared
Vanderbilt University1 shared
Alumni Ventures Group1 shared
Gaingels1 shared
Last updated: 3 March 2026